Overview Financials News + Filings Key Docs Ownership Insiders |
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
Revenues | 30.4 | 0.0 | 0.0 | 8.4 | 8.2 |
Revenue growth | | | -100.0% | 1.5% | |
Cost of goods sold | 50.2 | 0.0 | 0.0 | 16.7 | 12.7 |
Gross profit | -19.8 | 0.0 | 0.0 | -8.4 | -4.5 |
Gross margin | -65.2% | | | -100.0% | -54.9% |
Research and development | | 21.7 | 11.2 | | |
General and administrative | 19.8 | 15.8 | 7.5 | 4.1 | 4.5 |
EBIT | -50.2 | -37.5 | -18.7 | -12.4 | -12.7 |
EBIT margin | -165.2% | | | -148.9% | -154.9% |
Pre-tax income | -48.6 | -36.8 | -20.1 | -16.7 | -13.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -48.6 | -36.8 | -20.2 | 0.0 | 0.0 |
Net margin | -159.9% | | | -0.2% | -0.2% |
|
Diluted EPS | ($1.58) | ($1.33) | ($12.53) | ($55.92) | ($45.87) |
Shares outstanding (diluted) | 30.7 | 27.7 | 1.6 | 0.0 | 0.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|